Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
10/2000
10/11/2000EP1042297A1 Carboxyl acid substituted heterocycles as metalloproteinase inhibitors
10/11/2000EP1042296A1 Substituted isoquinoline derivatives and their use as anticonvulsants
10/11/2000EP1042295A1 4-hydroxyquinoline-3-carboxamides and hydrazides as antiviral agents
10/11/2000EP1042293A1 Substituted pyridine and pyridazine compounds and their pharmaceutical use
10/11/2000EP1042291A1 Aryl-substituted pyridylalkane, alkene, and alkine carboxamides useful as cytostatic and immunosuppressive agents
10/11/2000EP1042290A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
10/11/2000EP1042287A1 Indole derivatives as inhibitors of factor xa
10/11/2000EP1042279A1 Substituted beta-alanines
10/11/2000EP1041985A1 Combination of benzocycloheptapyridine compounds and antineoplastic drugs for treating proliferative diseases
10/11/2000EP1041982A1 INHIBITION OF p38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS
10/11/2000EP0773930B1 Aromatic amino ethers as pain relieving agents
10/11/2000CN1269794A 6,7-asymmetrically disubstituted quinoxalinecarboxylic acid derivatives, addition salts thereof and process for preparation of both
10/11/2000CN1269363A Method for proparing heterocyclic compound
10/11/2000CN1269362A 1,4-dichloropyridine-3,5-carboxylic-acid derivatives and preparation method thereof
10/11/2000CN1269359A Antimer pure acetacetates, its preparation method and use
10/11/2000CN1269358A Amino-butenate compound and preparation method thereof
10/11/2000CN1269357A Benzal compound and preparation method
10/11/2000CN1057297C Waterless crystallization of quinolone derivative and crystallization method of its 3/2 hydrate
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/10/2000US6130349 Catalytic compositions and methods for asymmetric allylic alkylation
10/10/2000US6130239 Inhibit cyclin-dependent kinases
10/10/2000US6130235 Piperidine moieties coupled to indole, benzimidazole or benzotriazole.
10/10/2000US6130234 4-substituted piperidine analogs and their use as subtype selective NMDA receptor antagonists
10/10/2000US6130233 Methods and compositions for treating allergic disorders and other disorders using metabolic derivatives of astemizole
10/10/2000US6130232 Substituted piperidine derivatives as muscarinic M3 receptor antagonists
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000US6130222 Analgesics
10/10/2000US6130220 Enzyme inhibitors
10/10/2000US6130188 Herbicidal pyridine compounds
10/10/2000US6129119 Flexible tube for lining pipes and ducts as well as method and an apparatus for manufacturing thereof
10/05/2000WO2000058405A2 Squaraine dyes
10/05/2000WO2000058313A1 4-substituted quinoline derivatives as gaba receptor ligands
10/05/2000WO2000058306A1 Substituted benzoylpyrazoles as herbicides
10/05/2000WO2000058305A1 Novel compounds
10/05/2000WO2000058303A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000WO2000058302A1 Dihydropyrimidines and their use in the treatment of hepatitis b
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000058288A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000WO2000058285A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders
10/05/2000WO2000057880A1 Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
10/05/2000WO2000042026B1 Non-peptide glp-1 agonists
10/05/2000DE19908483A1 Substances that inhibit cellular nicotinamide mononucleotide formation, useful for cancer therapy and immunosuppression
10/05/2000CA2471984A1 Compounds and method for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2368459A1 Substituted benzoylpyrazoles as herbicides
10/05/2000CA2368455A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands
10/05/2000CA2368451A1 Pyridine-2,3-dicarboxylic acid diamides
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2366263A1 Squaraine dyes
10/05/2000CA2361366A1 Novel compounds
10/04/2000EP1041071A1 Methods for the preparation of coumarine derivatives
10/04/2000EP1041066A1 Steroid receptor modulator compounds and methods
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040111A1 Integrin receptor antagonists
10/04/2000EP1040108A1 Ortho-anthranilamide derivatives as anti-coagulants
10/04/2000EP1040101A1 Substituted 2-aryl-4-amino-chinazolines, method for the production and use thereof as medicaments
10/04/2000EP1040099A1 Azepine or larger medium ring derivatives and their use as pharmaceuticals
10/04/2000EP1040098A1 Integrin receptor antagonists
10/04/2000EP1039908A1 Molecular dispersion composition with enhanced bioavailability
10/04/2000EP1039905A1 Pharmaceutical formulation comprising glycine as a stabilizer
10/04/2000EP1039886A1 Hiv/fiv protease inhibitors having a small p3 residue
10/04/2000EP1039884A1 A method for the prevention and treatment of stunned myocardium
10/04/2000EP1019040A4 INHIBITION OF p38 KINASE ACTIVITY BY ARYL UREAS
10/04/2000EP0912556B1 Indoline derivatives useful as 5-ht-2c receptor antagonists
10/04/2000EP0766672B1 Arylsulfonamido-substituted hydroxamic acids as matrix metalloproteinase inhibitors
10/04/2000EP0765311B1 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl)piperidines, tetrahydropyridines or piperazines
10/04/2000CN1268352A Method for preparing medicinal prepns. contg. 6-heterocycle-4-amino-1,3,4,5-tetrabenzo [cd] indole
10/04/2000CN1057088C Benzimidazole, prepn. method and use thereof
10/04/2000CN1057086C Phenylsulfonyl ureas, process for preparing same, and use as herbicide, herbicide composition contg. same
10/03/2000US6127544 1-substituted-3-ureido-indolin-2-ones which exhibit selective antagonism against gastrin receptors without causing side effects attributed to cck-a receptor antagonism; such as for treatment of peptic ulcers, gastritis
10/03/2000US6127403 An enzyme inhibitor for treating arteriosclerotic lesions of arteriosclerosis, hyperlipemia and diabetes, as well as ischemic diseases of brain, heart
10/03/2000US6127402 5-aroylpyrrol-2-ylmethylarene derivatives
10/03/2000US6127399 Certain pyrazole derivatives as cortiocotropin-releasing factor receptor CRF1 specific ligands
10/03/2000US6127396 Imidazoline compounds
10/03/2000US6127390 Antitumor agents inhibiting farnesyl-protein transferase, for treating cancer
10/03/2000US6127389 Benzimidazole derivatives as bradykinin agonists
10/03/2000US6127387 Use of CD4-binding small molecules to inhibit immune responses
10/03/2000US6127386 Stimulants, neurotransmitters, cholinergic agents
10/03/2000US6127384 Compounds, compositions and methods for treatment of hepatitis C
10/03/2000US6127383 Treatment of arteriosclerosis
10/03/2000US6127380 4-aminoalkoxy-1H-benzoimidazoles
10/03/2000US6127378 Phenanthridines substituted in the 6 position
10/03/2000US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
10/03/2000US6127375 A 4,4-disubstituted-3,4-dihydro-2(1h)-quinazolinthiones for treating viral infection
10/03/2000US6127374 An enzyme inhibitor for treating cancer, restenosis, atherosclerosis, endometriosis and psoriasis
10/03/2000US6127372 Sulfonamide inhibitors of aspartyl protease
10/03/2000US6127366 Inhibitors of farnesyl-protein transferase
10/03/2000US6127360 Antihistamines, antileukotrienes, antiinflammatory agents, antiasthmatic agents
10/03/2000US6127357 N-((phenyl, benzodioxinyl or N-heteroarylpiperazinyl)alkyl)-N-(N-heteroaryl)substituted carboxamides
10/03/2000US6127343 Selective, competitive somatostatin receptor ligands of nonpeptide origin, for mediating the biological effect of somatostatin agonists or antagonist
10/03/2000US6126932 Insoluble polymer bearing pendant side chains, said side chains each terminating with the 1-(3-(1-pyrrolidinyl)-propyl)-3-ethylcarbodiimide moiety.
09/2000
09/28/2000WO2000056730A1 PROCESS FOR PREPARING [S-(R*,S*)] -β -[[[1-[1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES
09/28/2000WO2000056729A1 Chemokine recpetor binding heterocyclic compounds
09/28/2000WO2000056720A1 Quinazolines and therapeutic use thereof
09/28/2000WO2000056712A1 Sulfonamide derivatives as 5-ht7 receptor antagonists
09/28/2000WO2000056710A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors
09/28/2000WO2000056709A1 Indolinone compounds as kinase inhibitors
09/28/2000DE19914140A1 Substituierte Benzoylpyrazole Substituted benzoylpyrazoles
09/28/2000CA2368047A1 Chemokine receptor binding heterocyclic compounds
09/28/2000CA2368041A1 Indolinone compounds as kinase inhibitors
09/28/2000CA2368024A1 Process for preparing [s-(r*,s*)]-.beta.-[[[1-[1-oxo-3-(4-piperidinyl)propyl]-3-piperidinyl]carbonyl]amino]-3-pyridinepropanoic acid and derivatives